Zentalis Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 3.95 M | $5.33 M | 705.70% | 5.47% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.88 M | $3.89 M | 24.01% | 4.00% |
| VANGUARD GROUP INC | 01/29/2026 | 2.86 M | $3.86 M | -1.68% | 3.96% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 2.85 M | $3.84 M | 0.15% | 3.95% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.96 M | $2.65 M | -5.44% | 2.72% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.66 M | $2.24 M | 17.86% | 2.30% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 1.48 M | $2.00 M | 1.53% | 2.06% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.47 M | $1.99 M | 7.93% | 2.04% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 1.40 M | $1.89 M | 342.55% | 1.94% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.37 M | $1.85 M | -11.72% | 1.90% |
| DECHENG CAPITAL LLC | 02/12/2026 | 1.32 M | $1.79 M | 0.00% | 1.83% |
| 02/17/2026 | 1.32 M | $1.78 M | 100.00% | 1.83% | |
| BLACKROCK, INC. | 02/12/2026 | 1.25 M | $1.69 M | 0.04% | 1.73% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 1.17 M | $1.58 M | 8.53% | 1.62% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/11/2026 | 957.42 K | $1.29 M | -0.54% | 1.33% |
| PFIZER INC | 02/12/2026 | 953.83 K | $1.29 M | 0.00% | 1.32% |
| MORGAN STANLEY | 02/13/2026 | 803.65 K | $1.08 M | -42.92% | 1.11% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 787.06 K | $1.06 M | 106.67% | 1.09% |
| UBS GROUP AG | 01/29/2026 | 674.60 K | $910.71 K | 26.64% | 0.94% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 673.13 K | $908.72 K | -25.42% | 0.93% |
| ALMITAS CAPITAL LLC | 02/17/2026 | 610.07 K | $823.60 K | 33.40% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 589.11 K | $795.72 K | -0.02% | 0.82% |
| XTX TOPCO LTD | 02/17/2026 | 576.71 K | $778.55 K | 5.12% | 0.80% |
| BARCLAYS PLC | 02/13/2026 | 568.44 K | $767.40 K | 252.04% | 0.79% |
| WOODLINE PARTNERS LP | 02/17/2026 | 530.58 K | $716.29 K | 0.00% | 0.74% |
| JANE STREET GROUP, LLC | 02/12/2026 | 473.18 K | $638.79 K | -26.71% | 0.66% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 463.70 K | $626.00 K | 2.18% | 0.64% |
| PEAPOD LANE CAPITAL LLC | 01/28/2026 | 448.86 K | $605.96 K | -20.61% | 0.62% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 419.37 K | $566.15 K | 163.86% | 0.58% |
| STATE STREET CORP | 02/13/2026 | 271.79 K | $366.92 K | 0.00% | 0.38% |
| CREATIVE PLANNING | 02/17/2026 | 260.00 K | $351.00 K | 0.00% | 0.36% |
| MARSHALL WACE, LLP | 02/13/2026 | 247.79 K | $334.51 K | 100.00% | 0.34% |
| FMR LLC | 02/17/2026 | 243.31 K | $328.47 K | 19.68% | 0.34% |
| ANFIELD CAPITAL MANAGEMENT, LLC | 02/03/2026 | 242.61 K | $327.52 K | 239.89% | 0.34% |
| INVESCO LTD. | 02/19/2026 | 188.58 K | $254.59 K | 8.62% | 0.26% |
| JPMORGAN CHASE & CO | 02/11/2026 | 185.01 K | $249.76 K | -74.41% | 0.26% |
| SEI INVESTMENTS CO | 02/13/2026 | 167.10 K | $225.59 K | 0.00% | 0.23% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 137.57 K | $185.72 K | 126.82% | 0.19% |
| QUARRY LP | 02/13/2026 | 132.00 K | $178.20 K | 21.38% | 0.18% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 01/08/2026 | 130.41 K | $232.12 K | -21.58% | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 124.53 K | $168.11 K | -82.23% | 0.17% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 118.21 K | $159.59 K | -65.75% | 0.16% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 110.45 K | $149.11 K | -8.30% | 0.15% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 107.73 K | $145.44 K | 405.27% | 0.15% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 100.29 K | $135.39 K | 100.00% | 0.14% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 96.26 K | $129.94 K | -47.97% | 0.13% |
| NORTHERN TRUST CORP | 02/17/2026 | 92.87 K | $125.38 K | -1.33% | 0.13% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 90.91 K | $122.73 K | -40.25% | 0.13% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 86.64 K | $116.96 K | -11.50% | 0.12% |
| RBF CAPITAL, LLC | 02/17/2026 | 80.00 K | $108.00 K | 0.00% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zentalis Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 124 institutional investors and hedge funds held shares of Zentalis Pharmaceuticals Inc. The most heavily invested institutionals were:
Peapod Lane Capital LLC: 366,868
UBS Group AG: 155,704
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC: 78,740
COMMONWEALTH EQUITY SERVICES, LLC: 61,412
Private Advisor Group, LLC: 31,472
Regency Capital Management Inc.\DE: 29,500
56.27% of Zentalis Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 48.27 M shares in the last 24 months. This purchase volume represents approximately $119.70 M in transactions.